View Author
scopus: 7006435877

Nagelkerken, L.

( L. Nagelkerken)


atopic dermatitis dermatiti treatment apoc 1 mice cream atopic tacrolimu tacrolimus ointment disease ointment effect serum patient level severity epidermal skin barrier function figure transepidermal water loss study fp cream mouse thickness alzheimer il -6 mast cells cetomacrogolis cream number barrier score petrolatum control development symptom netherland three-item severity score wet-wrap epidermal thickness serum levels dermatology function water result dilution serum il -6 british journal protein emollient epidermal hyperplasia 3 weeks ef ficacy children response oranje apolipoprotein c 1 dementia 6 weeks 2 weeks cetomacrogoli section 12 weeks model interleukin wild-type mice fl uticasone propionate mann –whitney u-test apoc 1 bene ficial effects ige þ cells excoriation weight wet-wrap occlusion occlusion kruskal –wallis test moisturizing cream propionate signi formulation uticasone




4 Most Recent Publications

Wet-wrap treatment using dilutions of tacrolimus ointment and fluticasone propionate cream in human APOC1 (+/+) mice with atopic dermatitis (Article)
Oranje, A.P. Verbeek, R. Verzaal, P. Haspels, I. Prens, E.P. Nagelkerken, L.
2009-01-01
Development of atopic dermatitis in mice transgenic for human apolipoprotein C1 (Article)
Nagelkerken, L. Verzaal, P. Lagerweij, T. Persoon-Deen, C. Berbee, J.F.P. Prens, E.P. Havekes, L.M. Oranje, A.P.
2008-05-01
Decreased sensitivity to dexamethasone in lymphocytes from patients with Alzheimer's disease (Article)
Nijhuis, E. Hinloopen, B. Duijn, C.M. van Rozing, J. Nagelkerken, L. Hofman, A.
1994-10-12
Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease (Article)
Duijn, C.M. van Nagelkerken, L. Hofman, A.
1990-01-01